The Board of Directors of the Company, at its meeting held today i.e. May 19, 2026, has considered and passed the following resolutions: 1) Cessation of the Company as a Partner of Subsidiary; ....
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 2.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Organics' Board has approved the company's cessation as a partner of Dhanvallabh Ventures LLP (DVLLP), which will cause DVLLP to cease being a subsidiary. As settlement consideration, the company will receive 1,86,07,531 equity shares of Valiant Laboratories Limited. The transaction is a related party transaction valued at fair market value on an arm's length basis, supported by a valuation report from GBCA & Associates LLP dated May 19, 2026. DVLLP contributed 0.05% of consolidated turnover (Rs. 0.3756 Crores) and 11.34% of net worth (Rs. 83.79 Crores) for Fiscal 2026. The transaction requires shareholder approval via special resolution and is expected to complete within 60 days of receiving such approval.
The divestment of the partnership interest in DVLLP will reduce the company's consolidated net worth by approximately 11.34%. Shareholders are being asked to approve this related party transaction which converts the partnership stake into equity shares of Valiant Laboratories Limited.